Latest News

Amyloid and Tau Biomarkers of Alzheimer Disease Found in Individuals with Other Dementias / image credit courtesy of Sahlgrenska University Hospital
Amyloid and Tau Biomarkers of Alzheimer Disease Found in Individuals with Other Dementias

April 29th 2025

Biomarkers in a pattern characteristic of Alzheimer pathology were identified in unspecified dementia, Parkinson dementia, and frontotemporal dementia.

For Patients with Migraine who do Not Initially Respond to CGRP Inhibitor Therapy, Switching mAbs May Provide Relief / image credit courtesy of Fundación Jiménez Díaz University Hospital
Switching Anti-CGRP Monoclonal Antibody Therapy in Nonresponders with Migraine May Reduce Monthly Headache Days

April 29th 2025

Metabolic Syndrome Linked to Risk of Young Onset Dementia
Metabolic Syndrome Linked to Risk of Young Onset Dementia

April 28th 2025

Early Menopause Was Associated with Increased Risk of Cognitive Decline, Depression within 2 Years / image credit Miharu Nakanishi, PhD Courtesy of World Dementia Council
Early Menopause Was Associated with Increased Risk of Cognitive Decline, Depression within 2 Years

April 22nd 2025

One in Three Cases of Dementia May be Attributable to Hearing Loss: Population-Based Study
One in Three Cases of Dementia May be Attributable to Hearing Loss: Population-Based Study

April 22nd 2025

Latest CME Events & Activities

BURST Expert Illustrations and Commentaries™: Visualizing FcRn as a Therapeutic Target in Neurological Disease

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of FcRN in Neurological Disorders

View More

BURST Expert Illustrations and Commentaries™: Visualizing the Implications of FcRN-Targeted Therapies on Generalized Myasthenia Gravis

View More

Burst Expert Illustrations & Commentary™: Visualizing the Role of Subcutaneous Infusion as an Alternate Administration Route for Medical Interventions

View More

Clinical Consultations™: Navigating the Evolving Treatment Landscape in Generalized Myasthenia Gravis

View More

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Carolina Neuromuscular Disease Summit

September 27, 2025

Register Now!

Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

SimulatEd™ From Discomfort to Relief: Acute Pain Management Essentials

View More

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

View More

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

View More

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

View More

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

View More

Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

View More

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

View More

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

View More

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

View More

Identifying and Treating CIDP in the Modern Era

View More

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

View More

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

View More

Medical Crossfire®: Optimal Approaches to Evaluating and Addressing Pain in the Patient With Sickle Cell Disease

View More

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

View More

© 2025 MJH Life Sciences

All rights reserved.